[HTML][HTML] Antimicrobial peptides for combating drug-resistant bacterial infections

J Xuan, W Feng, J Wang, R Wang, B Zhang, L Bo… - Drug Resistance …, 2023 - Elsevier
The problem of drug resistance due to long-term use of antibiotics has been a concern for
years. As this problem grows worse, infections caused by multiple bacteria are expanding …

Epidemiology of mobile colistin resistance genes mcr-1 to mcr-9

Z Ling, W Yin, Z Shen, Y Wang, J Shen… - Journal of …, 2020 - academic.oup.com
The identification of the first mobile colistin resistance (MCR) gene, mcr-1, in 2015 triggered
a rash of mcr screening reports. Subsequently, nine MCR-family genes and their variants …

Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association …

SW Biggins, P Angeli, G Garcia‐Tsao, P Ginès… - …, 2021 - Wiley Online Library
This AASLD Guidance provides a data-supported approach to the management of ascites
and HRS. It differs from the AASLD Guidelines, which are supported by systematic reviews …

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

P Angeli, M Bernardi, C Villanueva, C Francoz… - Journal of …, 2018 - Elsevier
The natural history of cirrhosis is characterised by an asymptomatic compensated phase
followed by a decompensated phase, marked by the development of overt clinical signs, the …

Guidelines on the management of ascites in cirrhosis

GP Aithal, N Palaniyappan, L China, S Härmälä… - Gut, 2021 - gut.bmj.com
The British Society of Gastroenterology in collaboration with British Association for the Study
of the Liver has prepared this document. The aim of this guideline is to review and …

Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: results of the ELITA/EF-CLIF collaborative study (ECLIS)

LS Belli, C Duvoux, T Artzner, W Bernal, S Conti… - Journal of …, 2021 - Elsevier
Background & Aims Liver transplantation (LT) has been proposed as an effective salvage
therapy even for the sickest patients with acute-on-chronic liver failure (ACLF). This large …

Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease

MA Odenwald, H Lin, C Lehmann, NP Dylla… - Nature …, 2023 - nature.com
Progression of chronic liver disease is precipitated by hepatocyte loss, inflammation and
fibrosis. This process results in the loss of critical hepatic functions, increasing morbidity and …

Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe

J Fernández, V Prado, J Trebicka, A Amoros… - Journal of …, 2019 - Elsevier
Background & Aims Antibiotic resistance has been increasingly reported in patients with
decompensated cirrhosis in single-center studies. Prospective investigations reporting …

Management of bacterial and fungal infections in cirrhosis: The MDRO challenge

J Fernández, S Piano, M Bartoletti, EQ Wey - Journal of hepatology, 2021 - Elsevier
Bacterial infections are frequent in cirrhotic patients with acute decompensation or acute-on-
chronic liver failure and can complicate the clinical course. Delayed diagnosis and …

The evolving challenge of infections in cirrhosis

JS Bajaj, PS Kamath, KR Reddy - New England Journal of …, 2021 - Mass Medical Soc
Infections in Patients with Cirrhosis Patients with cirrhosis are at increased risk for serious
infections, including spontaneous bacterial peritonitis, multidrug-resistant infection, and …